Caris Life Sciences Options were exercised for 400,000 shares at $2.44 each, while a separate transaction sold 400,000 shares at $30.33 each on 2026-09-17. For investors tracking CAI ownership, the records show 630,303 shares after the exercise and 230,303 after the sale.

Key Highlights

  • Brille Brian J held 1,600,000 derivative securities after exercising options for 400,000.
  • The separate share sale was priced at $30.33 per share.
  • The option exercise represented about 20.0% of the prior derivative securities holding.

Caris Life Sciences, Inc. (NASDAQ: CAI) is a biotechnology company. Brille Brian J exercised options for 400,000 shares at $2.44 per share on 17 September 2026, alongside a separate sale of 400,000 shares at $30.33 per share.

Option Exercise and Share Sale Details

The M transaction code identifies an option exercise involving Caris Life Sciences shares. After that transaction, Brille Brian J held 630,303 shares, with the exercise representing about 63.5% of the resulting share holding. The separate S-coded transaction sold 400,000 shares at $30.33 per share and left Brille Brian J with 230,303 shares, equal to about 63.5% of the prior share holding.

Derivative Securities Position

The option exercise also covered 400,000 derivative securities. Brille Brian J held 1,600,000 derivative securities after the transaction. The exercised amount represented about 20.0% of the prior derivative securities holding.